• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Ellagic Acid

Ellagic Acid

Product ID E4444
Cas No. 476-66-4
Purity ≥98%
Product Unit SizeCostQuantityStock
1 g $92.00 In stock
5 g $183.60 In stock
10 g $246.50 In stock
50 g $836.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ellagic acid is a phenol found in various fruits that exhibits neuroprotective, anti-angiogenic, anti-inflammatory, anti-asthma, anti-allergic, antiviral, antioxidative, anti-parasitic, antimalarial, anticancer, and anti-ulcerative activities. Ellagic acid inhibits HIF-1α-induced PI3K/Akt and VEGF/VEGFR2 signaling, downregulates expression of HDAC6, and suppresses neovascularization and angiogenesis in vitro and in vivo. In animal models of OVA-induced allergy, ellagic acid decreases eosinophil infiltration, Th2 cytokine release, IgE levels, and NF-κB activation, preventing airway hyperresponsiveness. In vitro, ellagic acid upregulates expression of HDAC9 and decreases differentiation of adipocytes. This compound inhibits proliferation of Plasmodium and Rhinovirus. In animal models of inflammation, ellagic acid increases levels of glutathione and IL-10 and decreases levels of NO, maldionaldehyde, IL-1β, TNF-α, COX-2, and NF-κB. In pancreatic adenocarcinoma cells, this compound suppresses cellular proliferation and induces apoptosis. Ellagic acid also inhibits the formation of ulcers in animal models.

Product Info

Cas No.

476-66-4

Purity

≥98%

Formula

C14H6O8

Formula Wt.

302.20

Chemical Name

2,3,7,8-Tetrahydroxy-[1]benzopyrano[5,4,3-cde][1]benzopyran-5,10-dione

IUPAC Name

6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

Synonym

Benzoaric acid, Lagistase.

Melting Point

>300°C

Solubility

Very slightly soluble in water. Soluble in 1 N NaOH (10 mg/mL).

Appearance

Brown/Yellow Solid

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

E4444 MSDS PDF

Info Sheet

E4444 Info Sheet PDF

References

Zhou E, Fu Y, Wei Z, et al. Inhibition of allergic airway inflammation through the blockage of NF-κB activation by ellagic acid in an ovalbumin-induced mouse asthma model. Food Funct. 2014 Sep;5(9):2106-12. PMID: 24998475.

Kang I, Okla M, Chung S. Ellagic acid inhibits adipocyte differentiation through coactivator-associated arginine methyltransferase 1-mediated chromatin modification. J Nutr Biochem. 2014 Sep;25(9):946-53. PMID: 24929439.

Kowshik J, Giri H, Kiran Kishore TK, et al. Ellagic Acid Inhibits VEGF/VEGFR2, PI3K/Akt and MAPK Signaling Cascades in the Hamster Cheek Pouch Carcinogenesis Model. Anticancer Agents Med Chem. 2014 Jul 23. [Epub ahead of print]. PMID: 25060902.

Park SW, Kwon MJ, Yoo JY, et al. Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinoviruses. BMC Complement Altern Med. 2014 May 26;14:171. PMID: 24885569.

El-Shitany NA, El-Bastawissy EA, El-desoky K. Ellagic acid protects against carrageenan-induced acute inflammation through inhibition of nuclear factor kappa B, inducible cyclooxygenase and proinflammatory cytokines and enhancement of interleukin-10 via an antioxidant mechanism. Int Immunopharmacol. 2014 Apr;19(2):290-9. PMID: 24534771.

Njomnang Soh P, Witkowski B, Gales A, et al. Implication of glutathione in the in vitro antiplasmodial mechanism of action of ellagic acid. PLoS One. 2012;7(9):e45906. PMID: 23029306.

Beserra AM, Calegari PI, Souza Mdo C, et al. Gastroprotective and ulcer-healing mechanisms of ellagic acid in experimental rats. J Agric Food Chem. 2011 Jul 13;59(13):6957-65. PMID: 21644797

Feng Y, Yang SG, Du XT, et al. Ellagic acid promotes Abeta42 fibrillization and inhibits Abeta42-induced neurotoxicity. Biochem Biophys Res Commun. 2009 Dec 25;390(4):1250-4. PMID: 19878655.

Edderkaoui M, Odinokova I, Ohno I, et al. Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. World J Gastroenterol. 2008 Jun 21;14(23):3672-80. PMID: 18595134.

Zhao M, Tang SN, Marsh JL, et al. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice. Cancer Lett. 2013 Sep 1;337(2):210-217. PMID: 23684930.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • N3310

    Nicotinamide

    Amide form of vitamin B3 required for productio...

    ≥98%
  • T6834

    Triacsin C

    Acyl-CoA synthetase inhibitor.

    ≥95%
  • B242042

    BGB-283

    Dual RAF/EGFR inhibitor.

    ≥98%
  • O1200

    Odanacatib

    Cathepsin K inhibitor.

    ≥99%
  • D5690

    Doxazosin Mesylate

    Quinazoline; α1-adrenergic antagonist.

    ≥98%
  • T1670

    Terazosin Hydrochloride Dihydrate

    Quinazoline; α1-adrenergic antagonist.

    ≥98%
  • D3356

    Diosmetin

    O-methylated flavone found in vetch and various...

    ≥98%
  • T3185

    Thymidine

    Pyrimidine nucleoside base, pairs with adenosin...

    ≥98%
  • R3312

    Ridaifen A Dihydrochloride

    Tamoxifen derivative; potential proteasome inhi...

    ≥98%
  • A0817

    D,L-1’-Acetoxychavicol acetate

    TRPA1 agonist, xanthine oxidase inhibitor.

    ≥98%
  • B1996

    BEZ235

    PI3K and mTOR inhibitor.

    ≥98%
  • M185777

    4-(Methylsulfinyl) butylamine

    ≥99%
  • Z4833

    ZM-336372

    c-Raf inhibitor, tyrosine kinase inhibitor.

    ≥98%
  • S800000

    SU-9516

    CDK2 inhibitor.

    ≥98%
  • E2002

    Efaroxan Hydrochloride

    α2-adrenergic and imidazoline-1 antagonist, AT...

    ≥99%
  • P6954

    Pioglitazone Hydrochloride

    Thiazolidinedione; PPARα/γ agonist, mitoNEET ...

    ≥98%
  • P7033

    Primaquine Phosphate

    Alters membrane permeability, prevents transpor...

    ≥98% (titration)
  • T1656

    Tenoxicam Impurity B

    Tenoxicam impurity

    ≥98%
  • G880000

    GW 405833

    Cannabinoid receptor 2 selective agonist.

    ≥98%
  • L5751

    Lomerizine Dihydrochloride

    L-type and T-type Ca2+ and TRP antagonist.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only